Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Investments Regulatory News (BRH)

  • There is currently no data for BRH

Disposal

13 Dec 2013 12:29

RNS Number : 5122V
Braveheart Investment Group plc
13 December 2013
 



13 December 2013

 

Braveheart Investment Group plc

('Braveheart', the 'Company' or the 'Group')

 

Disposal of Envestors

 

Braveheart Investment Group plc (the 'Group' or the 'Company'), the AIM-listed investment management group providing debt and equity capital to SMEs and servicing the investment requirements of business angels, high net worth individuals, family offices, and public sector organisations announces that it has sold Envestors Ltd ('Envestors'), one of its subsidiaries, to a management buy-out team. 

 

The sale follows the decision by the Braveheart Board to exit the business for the following reasons:

 

· Whilst Envestors has shown steady growth since its acquisition in 2010, it has not performed in line with expectations and has not contributed positively to the Group's financial performance. Furthermore, recent trading has been poor and the business has made significant losses due to high fixed costs; and

 

· Envestors provides corporate finance advisory services; as such there is little forward visibility on revenue, which in any case tends to be volatile. This model does not fit with the Group's strategy of building a business based on long-term contracted revenue. 

 

Notwithstanding the sale of Envestors, the two businesses will continue to collaborate on certain initiatives for mutual benefit. 

 

The consideration for the sale is the cancellation of the final Braveheart share issue due to the three management buy-out participants, as agreed at the time of the Envestors acquisition and detailed within the Group's 2013 Annual Report. Consequently, 882,971 new Braveheart shares will now not be issued. A fourth member of the management team, who exited the business in March 2013, will still be issued with 324,924 new Braveheart shares and application for these shares to be admitted to AIM will be made shortly.

 

Two members of the management buy-out team are directors of Envestors and the disposal is therefore a related party under the AIM Rules. The Directors of Braveheart, having consulted with the Company's nominated adviser, consider the terms of the disposal to be fair and reasonable insofar as shareholders are concerned.

 

The rest of the Group's operating companies are trading in-line with expectations and this divestment will enable the Group to concentrate its resources on growing its fund management business. The Group expects to announce its interim results for the six months ended 30 September 2013 shortly.

 

Further information:

 

Braveheart Investment Group plc

Geoffrey Thomson, Chief Executive

gthomson@braveheartgroup.co.uk

Tel: 01738 587555

 

 

Sanlam Securities UK Limited (Nominated Adviser and Broker to Braveheart)

Lindsay Mair

Catherine Miles

Tel: 020 7628 2200

 

 

Media enquiries:

Allerton Communications

Peter Curtain

peter.curtain@allertoncomms.co.uk

Tel: 020 3137 2500

 

Notes to Editors

 

Braveheart Investment Group plc

 

Braveheart provides financing for small and medium sized enterprises (SMEs) as follows: 

 

For the company looking to raise money, we provide:

 

· Equity capital. This form of financing is typically long term and is usually appropriate for fast growing businesses or early stage companies. We will consider equity financings where our individual investment, or the investment we arrange, would normally be a maximum of £2m although we are happy to participate in larger financings as part of a syndicate;

· Debt finance. Short to medium term and for companies with cash flow to service the loan. Our unit size for this type of finance is up £1m and we will usually provide junior debt which is unsecured but linked to an equity instrument;

 

The money we invest comes from a variety of sources (see below) and is sometimes linked to particular geographical locations.

 

To the investor, we provide a one stop shop service to those in one of the following groups who are looking for exposure to SME investments:

 

· High net worth (HNW) individuals looking to build tax efficient Enterprise Investment Scheme (EIS) and Seed EIS portfolios;

· Family offices and private sector institutions;

· The Public sector.

 

Investors can choose between investment types ranging from self-build portfolios, to a full fund management service.

 

www.braveheartgroup.co.uk

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISGGGMPPUPWGPW
Date   Source Headline
19th May 202012:48 pmRNSHolding(s) in Company
11th May 20208:51 amRNSHolding(s) in Company
11th May 20207:01 amRNSHolding(s) in Company
11th May 20207:00 amRNSHolding(s) in Company
7th May 20206:15 pmRNSHolding(s) in Company
6th May 20207:00 amRNSUpdate in response to social media speculation
4th May 20204:41 pmRNSSecond Price Monitoring Extn
4th May 20204:36 pmRNSPrice Monitoring Extension
4th May 20207:00 amRNSFurther re Kirkstall Limited
1st May 20207:00 amRNSFurther Placing to raise £350,000
29th Apr 20204:40 pmRNSSecond Price Monitoring Extn
29th Apr 20204:36 pmRNSPrice Monitoring Extension
29th Apr 20207:00 amRNSPlacing to raise £275,000
27th Apr 202011:05 amRNSSecond Price Monitoring Extn
27th Apr 202011:00 amRNSPrice Monitoring Extension
23rd Apr 20207:00 amRNSOperational update re certain investments
14th Apr 20207:00 amRNSOperational update on the Strategic Investments
3rd Mar 20207:00 amRNSOperational Update and Strategic Investments
30th Jan 20207:00 amRNSOperational update on Strategic Investments
12th Dec 20197:00 amRNSFurther investment in Pharm 2 Farm Limited
21st Nov 20197:00 amRNSOperational update on strategic investments
31st Oct 201910:55 amRNSHalf-year Report
28th Oct 20195:12 pmRNSFurther re buying remaining shares of Paraytec
19th Sep 20197:00 amRNSResults of customer trials by Pharm2Farm Limited
18th Sep 20197:00 amRNSDiscussions to buy remaining shares of Paraytec
29th Aug 201912:20 pmRNSResult of AGM
5th Aug 20197:00 amRNSPosting of annual accounts
1st Aug 20193:27 pmRNSREPLACEMENT: Final Results
1st Aug 20197:00 amRNSFinal Results
8th Jul 20197:00 amRNSInvestment in Pharm2Farm Limited
7th Jun 20197:00 amRNSUpdate to the Market
16th Apr 20197:00 amRNSDisposal of Viking Fund Managers Limited
12th Feb 201910:25 amRNSHolding(s) in Company
31st Jan 20195:17 pmRNSHolding(s) in Company
13th Dec 20187:00 amRNSFund Management Division Update
30th Oct 20187:00 amRNSInterim Results
18th Oct 201811:28 amRNSUpdate re Reduction of Share Capital
24th Sep 20189:00 amRNSConversion of Loan Notes in Paraytec Limited
4th Sep 20187:00 amRNSFurther re. Partial Disposal of Investment
21st Aug 20187:00 amRNSPartial Disposal of Investment in Gyrometric
19th Jul 201812:15 pmRNSResult of AGM and GM
16th Jul 20187:00 amRNSUpdate on fund management business
12th Jul 20187:00 amRNSProposed funding round by Paraytec Limited
10th Jul 201810:44 amRNSHolding(s) in Company
25th Jun 20187:00 amRNSFurther re. Notice of Annual General Meeting
21st Jun 20185:16 pmRNSConfirmation of Posting
20th Jun 201810:30 amRNSAppointment of Joint Broker
18th Jun 20187:02 amRNSNotice of General Meeting
18th Jun 20187:00 amRNSFinal Results
26th Apr 20187:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.